Breve revisão bibliográfica sobre os efeitos do licopeno em neoplasias prostáticas
Article Sidebar
Main Article Content
Abstract
In this article, the activities of lycopene were addressed, looking for its functional properties and whether it is possible to use it as a way of preventing prostate cancer. For this, a bibliographic review was carried out, consulting Pubmed's database in the last ten years, in order to find out how lycopene, present in carotenoids such as tomatoes, watermelon, guava, among other foods, could be used for the cancer prevention mentioned above and whether there are scientific data to support this theory. The results show conflicting information, the vast majority of the data reviewed, does not present enough evidence to support the use of lycopene in the prevention of prostate cancer, however, in isolated cases, there was a decrease in cancerous markers after the increase in lycopene consumption.
Keywords: cancer; prostate cancer; lycopene.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright Statement - Policy Proposal for Open Access Journals
Authors who publish in the Brazilian Journal of Natural Sciences (BJNS) agree to the following terms: 1 - Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License allowing sharing of the work with recognition of the authorship of the work and initial publication in this journal. 2 - Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. 3 - Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and citation of published work. This is an open access article under the CC-BY license
(http://creativecommons.org/licenses/by/4.0)
References
Ministério da Saúde (Brasil) Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Câncer de próstata: Vamos falar sobre isso? Ministério da Saúde. 2017;
P R. Epidemiology of Prostate Cancer. World J Oncol. 2019;10(2):63–89. World J Oncol. 2019;
Gomes R, De Sousa Rebello LEF, De Araújo FC, Do Nascimento EF. A prevenção do câncer de próstata: Uma revisão da literatura. Ciencia e Saude Coletiva. 2008.
Migowski A, Silva GA e. Sobrevida e fatores prognósticos de pacientes com câncer de próstata clinicamente localizado. Rev Saude Publica. 2010;
Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, et al. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURETM). Prostate. 2018;
Chen P, Zhang W, Wang X, Zhao K, Negi DS, Zhuo L, et al. Lycopene and Risk of Prostate Cancer A Systematic Review and Meta-Analysis. Med. 2015;
Costa JAP, Costa JAP, Matias AGC. Câncer de próstata e a relação quimiopreventiva do licopeno: revisão sistematizada. Tempus Actas de Saúde Coletiva. 2015;
Grainger EM, Moran NE, Francis DM, Schwartz SJ, Wan L, Thomas-Ahner J, et al. A Novel Tomato-Soy Juice Induces a Dose-Response Increase in Urinary and Plasma Phytochemical Biomarkers in Men with Prostate Cancer. J Nutr. 2019;
Van Hoang D, Pham NM, Lee AH, Tran DN, Binns CW. Dietary carotenoid intakes and prostate cancer risk: A case-control study from Vietnam. Nutrients. 2018;
Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, et al. Serum lycopene concentration and prostate cancer risk: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2011;
Van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, et al. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized, controlled trial. Cancer Prev Res. 2011;
Magbanua MJM, Roy R, Sosa E V., Weinberg V, Federman S, Mattie MD, et al. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011;
Morgia G, Cimino S, Favilla V, Russo GI, Squadrito F, Mucciardi G, et al. Effects of Serenoa Repens, Selenium and Lycopene (Profluss®) on chronic inflammation associated with Benign Prostatic Hyperplasia: Results of “FLOG” (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre italian study. Int Braz J Urol. 2013;
Datta M, Taylor ML, Frizzell B. Dietary and serum lycopene levels in prostate cancer patients undergoing intensity-modulated radiation therapy. J Med Food. 2013;
S. M, L. L, M. C, A. T, D. R, C. DN, et al. Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. Int J Mol Sci. 2014;
Antwi SO, Steck SE, Zhang H, Stumm L, Zhang J, Hurley TG, et al. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer. Cancer Epidemiol. 2015;
Gann PH, Deaton RJ, Rueter EE, Van Breemen RB, Nonn L, Macias V, et al. A Phase II Randomized Trial of Lycopene-Rich Tomato Extract among Men with High-Grade Prostatic Intraepithelial Neoplasia. Nutr Cancer. 2015;
Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, et al. Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. Clin Nutr. 2017;
Beynon RA, Richmond RC, Santos Ferreira DL, Ness AR, May M, Smith GD, et al. Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial. Int J Cancer. 2019;
Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, et al. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG. Prostate. 2017;